SOLV — Solventum Corp
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1964738 ·
Last close
$78.01
Market Cap
$13.51B
52W High
$83.42
52W Low
$65.44
ADV30
1,198,926
Next earnings
2026-08-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 2,006,000,000 | 1,095,000,000 | 79,000,000 | 13,000,000 | 14,097,000,000 | 561,000,000 | 9,127,000,000 |
| Dec 2025 | 1,998,000,000 | 1,027,000,000 | 93,000,000 | 63,000,000 | 14,294,000,000 | 878,000,000 | 9,244,000,000 |
| Sep 2025 | 2,096,000,000 | 1,135,000,000 | 172,000,000 | 1,266,000,000 | 13,973,000,000 | 1,642,000,000 | 8,987,000,000 |
| Jun 2025 | 2,161,000,000 | 1,175,000,000 | 214,000,000 | 90,000,000 | 15,074,000,000 | 492,000,000 | 11,429,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$152,000,000
Investing CF
$2,834,000,000
Financing CF
$-2,968,000,000
CapEx
$-354,000,000
Dividends Paid
—
Buybacks
$-67,000,000
EPS Diluted TTM
$8.16
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$1,810,000,000
Inventory
$1,089,000,000
Receivables
$1,180,000,000
ST Investments
—
EBIT TTM
$1,996,000,000
Pretax Income TTM
$1,691,000,000
Interest Exp TTM
$305,000,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$8,262,000,128
EBITDA
$1,124,000,000
Free Cash Flow
$377,500,000
Enterprise Value
$18,239,358,976
Total Cash
$561,000,000
Total Debt
$5,290,999,808
Shares Out
173,174,712
Trailing EPS
$8.17
Book Value
$28.64
ROE
34.8%
ROA
2.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 8,325,000,000 | 632,000,000 | 1,556,000,000 | 14,294,000,000 | 9,244,000,000 | — | 369,000,000 |
| Dec 2024 | 8,254,000,000 | 1,036,000,000 | 479,000,000 | 14,457,000,000 | 11,498,000,000 | — | 1,185,000,000 |
| Dec 2023 | 8,197,000,000 | 1,636,000,000 | 1,346,000,000 | 13,943,000,000 | 2,277,000,000 | — | 1,915,000,000 |
| Dec 2022 | 8,130,000,000 | 1,693,000,000 | 1,343,000,000 | 13,594,000,000 | 1,852,000,000 | — | 1,679,000,000 |
TTM Snapshot
Revenues TTM
$4,156,000,000
NetIncome TTM
$582,000,000
OpCashFlow TTM
$0
Assets (Latest)
$14,457,000,000
Forward EPS
$7.09
Max Pain — expiry 2026-10-16
max pain strike: $70.00 · spot: $78.01 · call oi: 1,378 · put oi: 281
Expected Move to 2026-10-16:
±$9.85
(12.63%) —
implied range
$68.16 –
$87.86
· ATM straddle on $80.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SNN | SMITH & NEPHEW PLC | $12.86B | $30.57 | — |
| SNNUF | SMITH & NEPHEW PLC | $12.71B | $15.10 | — |
| PEN | Penumbra Inc | $12.54B | $318.73 | — |
| ALGN | ALIGN TECHNOLOGY INC | $11.96B | $167.01 | — |
| BAX | BAXTER INTERNATIONAL INC | $11.57B | $22.40 | — |
News headlines (Yahoo Finance, 1h cache)
3 Reasons SOLV is Risky and 1 Stock to Buy Instead
2026-07-24 19:37 · Yahoo
Here's Why You Should Hold Solventum Stock in Your Portfolio for Now
2026-07-24 14:00 · Yahoo
Solventum’s Q2 2026 Earnings: What to Expect
2026-07-22 10:36 · Yahoo
3M investors are still waiting for a more 'consistent' growth story
2026-07-21 15:12 · Yahoo
Solventum to Report Second Quarter Fiscal 2026 Earnings on August 5, 2026
2026-07-15 20:05 · Yahoo
2 S&P 500 Stocks to Own for Decades and 1 We Question
2026-07-07 09:38 · Yahoo
3 Mid-Cap Stocks We Steer Clear Of
2026-06-29 10:58 · Yahoo
3 Healthcare Stocks with Questionable Fundamentals
2026-06-25 10:49 · Yahoo
Solventum Stock: Is SOLV Underperforming the Healthcare Sector?
2026-06-22 06:25 · Yahoo
Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?
2026-06-16 12:07 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.